australasian neuroscience nurses association - PowerPoint PPT Presentation

Loading...

PPT – australasian neuroscience nurses association PowerPoint presentation | free to download - id: ed23-NzFlZ



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

australasian neuroscience nurses association

Description:

The month of September saw 100 ANNA members come together on the Gold Coast for ... In addition to this new member we welcome Nicole Morley to the Executive. ... – PowerPoint PPT presentation

Number of Views:531
Avg rating:5.0/5.0
Slides: 19
Provided by: rochelle4
Learn more at: http://dynacomm.info
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: australasian neuroscience nurses association


1
Issue 3, November 2005
Brainstem
www.anna.asn.au
  • Inside this issue
  • Presidents report
  • Conference news
  • WFNN News
  • State news
  • Membership
  • 2005 AGM minutes
  • Brainstem Evaluations
  • Special features
  • John Shead Biography
  • Huntingtons Disease
  • Onyx

I know that she is already busily planning next
years conference, which will see us heading up to
tropical Queensland in Cairns. Bring it
on! Cheryl will have more about the conference
in her report, but I can sum it up by saying it
was educational and fun (particularly the beach
theme dinner). If you want to see what ANNA
members got up to visit the ANNA website.   As
you will know we ran several competitions through
the year with the winners being announced at the
conference. Congratulations to the following
winners 33rd member to renew for 2005-2006
Rebecca Burke Most members recruited during the
week of ANND in May Royal North Shore Hospital,
Sydney. ANND celebration competition Sydney
West Area Health Service.  
Tracy taking the surf rider challenge
The end of the year and all of the festivities
that comes with it is fast approaching. This
will be our last BRAINSTEM for 2005 and on behalf
of the Executive team we wish you a safe and
merry Christmas and prosperous New Year. The
month of September saw 100 ANNA members come
together on the Gold Coast for our annual
scientific meeting (conference). It was great to
see so many members (both old and new)
participate in the sharing of neuroscience
knowledge and to network with fellow colleagues.
The diversity of the papers presented was
fantastic, with many areas relevant to
neuroscience nursing being addressed.
Congratulations to all of the presenters, in
particular our prize winners, Tim OMaley, Suzy
Goodman and Lucy Bailey. Cheryl (our friendly
conference convener) did a fantastic job
organising and coordinating the conference. The
great success of the conference, which was
evident from the evaluation responses, was
possible because of her dedication to every
detail in ensuring the conference met the needs
of ANNA members.
Our membership numbers have shown a steady rise
over the year, which is pleasing to see. It is
the members that strengthen our association and
we thank you for your support in continuing to
promote ANNA and recruit new members.   We
welcome to the Federal Executive Karen Tuqiri as
Treasurer. We look forward to Karen joining the
team and working together for the association.
australasian neuroscience nurses association
2
A Message from your Friendly Conference Convener
As I pack away the folder for conference 2005 and
label the 2006 folder I feel that you the members
deserve to read a somewhat bias report on the
33rd Annual Scientific Meeting. Legends Hotel,
Gold Coast QLD September 15th 17th 2005 was
the place to be according to _at_ 100 enthusiastic
ANNA members. On the Terrace with a drink in
one hand old friendships were reunited and new
ones started as delegates mingled amongst their
neuroscience colleagues. Tracy Desborough
welcomed all to our annual meeting and the
networking continued. 34 members submitted
abstracts for posters and oral presentations,
these submissions allowed the program to reflect
the diversity that Neuroscience Nursing
represents. Congratulations to our Prize winners,
all gave outstanding presentations representing
the work they do for Neuroscience patients
Tonnie Koenen Prize Tim OMaley
(QLD) Neurosurgical Society Australasia (NSA)
Prize Suzy Goodman (VIC) Poster Prize Kylie
Wright (NSW) First Time Presenter Lucy Bailey
(QLD) Congratulations to all presenters (oral
and poster) and moderators who expressed interest
in participating at a very successful conference,
I thank you and look forward to your support next
year.
3
I also look forward to the inundation of
abstract submissions we get when I post the call
for abstracts!! Remember the conference program
can only be as good as its content, which is up
to you the members. So if you want a longer
program or a more diverse program start thinking
about your abstract submission for next year now!
And tell your colleagues. As you know there is
more to a conference than just absorbing and
sharing knowledge, what about the social side or
in conference language networking
opportunities. The conference dinner is an
event that will be hard to beat, how many people
have now taken up surfing lessons or visited a
chiropractor??? How much fun was the mechanical
surf board and the dance floor both activities
proved that nurses are very talented people!! I
am sure there are storys being told around neuro
wards about who was the most talented on the surf
(Charmaine). Thank you all for a great night.
Thank you for attending and supporting our
conference it is always great to see our members
come together each year and share their
experiences. I look forward to seeing you all
next year. Bye for now Your Friendly
Conference Convener Cheryl Trudinger PS See you
in Cairns, September 14th 16th 2006
4
A tribute to John Shead - a biography
  • There is a beautiful saying…. Some people come
    into our lives and quickly go. Some stay awhile,
    leave footprints on our hearts. And we are never,
    ever the same.
  • For those who had the privilege of having met and
    known John Shead, would agree that John has left
    footprints in our hearts. Johns recent sudden
    and tragic passing had a profound effect on all
    staff, across all disciplines throughout Westmead
    Hospital. It goes without saying that Johns
    prescience within the hospital was always obvious
    and highly valued, and now his absence has left
    an equally obvious void and sense of immeasurable
    loss for many, many people.
  • John had been on the staff at Westmead for some
    twenty years and as such he had become an
    integral and much loved part of Westmead
    Hospital. John fulfilled many professional roles
    during his time, starting back in 1979 as a
    registered nurse. In 1981, John completed his
    midwifery training and stayed on staff
    thereafter. John subsequently ventured in to the
    world of Neural Sciences (some would say he took
    his job a bit too literally, as demonstrated by
    his shaved bald head!)
  • After he successfully did the Neurological Course
    at Westmead, John went on to become the Nurse
    Unit Manager of the Neuro High Dependency Unit
    (D5b), before later becoming the Clinical Nurse
    Consultant in Neural Sciences.
  • At one stage, John had completed more
    postgraduate courses at Westmead than any other
    nurse. In the last couple of years, John embraced
    the opportunity of a change in career direction
    and successfully fulfilled the role of Acting
    Facility Planner with the Maintenance and
    Facility department. This role assisted in
    raising the profile even higher and wider amongst
    the Westmead Hospital community and like his
    clinical career he took little time in proving
    what a highly valuable asset he was to the
    service.
  • John dedicated almost half his lifetime to
    Westmead and he has left behind an indelible
    legacy. Many people were probably unaware of the
    extent of his great work and commitment, to both
    his clinical specialty and the nursing profession
    in general. John was a regular and popular
    lecturer on Neuro specialty on local, national
    and international level. John was the epitome of
    the quiet achiever, who got on with the job,
    always doing the best job possible. One of Johns
    greatest achievements was his outstanding ability
    as a teacher and mentor.

Thank you to Angela Lownie and Kate Murphy from
the Western Area Health Service, Sydney for
providing this contribution
5
The 2005 World Congress on Huntingtons Disease
Impetus for change
Reported by Angela Lownie
  • The 2005 World Congress on Huntington Disease was
    held at the Midland Hotel, Manchester from 10
    13th September 2005. The program and abstracts
    have been published as Supplement lV in the
    Journal of neurology, neurosurgery and psychiatry
    (Oct 2005, Vol 76).
  • Along with 492 other participants, I spent the
    2.5 days absorbing what scientists, clinicians,
    and medical researchers from the fields of
    genetics, epidemiology, biochemistry, neurology,
    psychiatry, psychology, nursing, and general
    medicine, from every corner of the globe had to
    say about their work in understanding and
    overcoming, this baffling hereditary condition.
    Also there were care managers, administrators,
    and representatives of HD affected families
    through their local organizations, meeting
    together for an historic first time.
  • The high- powered work for a cure or treatments
    to slow down the progress of the disease are
    truly astonishing and would take an article on
    their own to discuss. Suffice it to say that
    collaborative international research papers spoke
    (amongst many others) of efforts to regulate the
    toxicity of mutant Huntington (Rubinsztein et al
    of the role of dopamine in restoring cortical
    function in HD mice (Cummings et al) of evidence
    of the role of mRNA dysfunction in producing
    pathology (Hodges et al) preliminary results of
    clinical trials of human striatal tissue
    transplant (Dunnett Brain repair group)
    investigation of the effects of miraxion (motor
    features), memantine (cognitive impairment),
    coenzyme Q (functional decline) and investigation
    of any impact on disease course (minocycline) as
    well as Creatine, Phenylbutyrate, EthylEPA,
    Rosagiline, Citicoline, Lamotrigine, MPEP and
    Amantidine.

I was fortunate to have the opportunity to
attend, assisted by a much appreciated
Professional Development Scholarship from ANNA.
With my service director, neurologist Dr
Elizabeth McCusker, I presented a poster Ten
years of Huntington Disease outreach service in
New South Wales on the 2nd day with eleven
others under the heading of Clinical Care and
Management. In spite of the rather crowded
display space, I had several conversations with
other participants during the hour long poster
viewing session regarding the functioning of our
service. I particularly enjoyed discussions
regarding late stage residential care with team
members from the Netherlands working in a 70 bed
specialist residential unit Overduin, in
Katwijk. By comparison to my previous
experience a few years ago, it was pleasing to
find an increasing number of papers and posters
targeting care and management issues at this key
event. Posters from the Leicester Partnership
Trust (UK), Nottingham (UK), Russia, and the
Netherlands (as mentioned), presented work with
common threads to ours. Once again, we were happy
that our work in this area compares favorably
when viewed from the International
standpoint. However, it was the in-depth
conversations with nurses such as Dr Elizabeth
Almquist from Sweden regarding their work on
assessing nursing interventions and strategies
for aggressive behaviour, and Steve Smith from
the University of East Anglia who used the
conference to launch his book Huntingtons
Disease a Nursing Guide Applying the Roper,
Logan and Tierney Model of Nursing, that
provided the greatest benefit.
An excellent paper by administrator jim pollard
and psychologist R.M. Stein, accommodating the
cognitive phenotype a challenge to nursing
homes and considerations for care was the final
impetus to animated conversations which resulted
in plans to launch the first international
network of non medical professionals in
HD. Some last minute drafting late into the
night and we had a document, outlining the aims
and plans, to disseminate to the participants at
the last plenary session. It is hoped that this
network might be a force for change with regard
to the noticeable lack of research by allied
health therapists and nurses. The next congress
will be in dresden, Germany in 2007, and it would
be wonderful to be able to report on some
collaborative endeavors to that meeting.
Interested nurses and allied health staff can
join through contacting me (angela_lownie_at_wsahs.Ns
w.Gov.Au) or Steve smith (steve.Smith_at_uea.Ac.Uk)
or Jim pollard (jpollard_at_comcast.Net)
6
What is Huntington's Disease?
  • Huntington's disease (HD) results from
    genetically programmed degeneration of brain
    cells, called neurons, in certain areas of the
    brain. This degeneration causes uncontrolled
    movements, loss of intellectual faculties, and
    emotional disturbance. HD is a familial disease,
    passed from parent to child through a mutation in
    the normal gene. Each child of an HD parent has a
    50-50 chance of inheriting the HD gene. If a
    child does not inherit the HD gene, he or she
    will not develop the disease and cannot pass it
    to subsequent generations. A person who inherits
    the HD gene will sooner or later develop the
    disease. Whether one child inherits the gene has
    no bearing on whether others will or will not
    inherit the gene. Some early symptoms of HD are
    mood swings, depression, irritability or trouble
    driving, learning new things, remembering a fact,
    or making a decision. As the disease progresses,
    concentration on intellectual tasks becomes
    increasingly difficult and the patient may have
    difficulty feeding himself or herself and
    swallowing. The rate of disease progression and
    the age of onset vary from person to person. A
    genetic test, coupled with a complete medical
    history and neurological and laboratory tests,
    help physician's diagnose HD. Presymptomic
    testing is available for individuals who are at
    risk for carrying the HD gene. In 1 to 3 percent
    of individuals with HD, no family history of HD
    can be found.
  • How is HD Diagnosed?
  • The great American folk singer and composer Woody
    Guthrie died on October 3, 1967, after suffering
    from HD for 13 years. He had been misdiagnosed,
    considered an alcoholic, and shuttled in and out
    of mental institutions and hospitals for years
    before being properly diagnosed. His case, sadly,
    is not extraordinary, although the diagnosis can
    be made easily by experienced neurologists.
  • A neurologist will interview the individual
    intensively to obtain the medical history and
    rule out other conditions. A tool used by
    physicians to diagnose HD is to take the family
    history, sometimes called a pedigree or
    genealogy. It is extremely important for family
    members to be candid and truthful with a doctor
    who is taking a family history.
  • The doctor will also ask about recent
    intellectual or emotional problems, which may be
    indications of HD, and will test the person's
    hearing, eye movements, strength, coordination,
    involuntary movements (chorea), sensation,
    reflexes, balance, movement, and mental status,
    and will probably order a number of laboratory
    tests as well.
  • People with HD commonly have impairments in the
    way the eye follows or fixes on a moving target.
    Abnormalities of eye movements vary from person
    to person and differ, depending on the stage and
    duration of the illness.
  • The discovery of the HD gene in 1993 resulted in
    a direct genetic test to make or confirm a
    diagnosis of HD in an individual who is
    exhibiting HD-like symptoms. Using a blood
    sample, the genetic test analyzes DNA for the HD
    mutation by counting the number of repeats in the
    HD gene region. Individuals who do not have HD
    usually have 28 or fewer CAG repeats. Individuals
    with HD usually have 40 or more repeats. A small
    percentage of individuals, however, have a number
    of repeats that fall within a borderline region
  • Is there any treatment?
  • Physicians prescribe a number of medications to
    help control emotional and movement problems
    associated with HD. Most drugs used to treat the
    symptoms of HD have side effects such as fatigue,
    restlessness, or hyperexcitability. It is
    extremely important for people with HD to
    maintain physical fitness as much as possible, as
    individuals who exercise and keep active tend to
    do better than those who do not.
  • What is the prognosis?
  • At this time, there is no way to stop or reverse
    the course of HD. Now that the HD gene has been
    located, investigators are continuing to study
    the HD gene with an eye toward understanding how
    it cause disease in the human body.
  • What research is being done?
  • Scientific investigations using electronic and
    other technologies enable scientists to see what
    the defective gene does to various structures in
    the brain and how it affects the body's chemistry
    and metabolism. Laboratory animals are being bred
    in the hope of duplicating the clinical features
    of HD so that researchers can learn more about
    the symptoms and progression of HD. Investigators
    are implanting fetal tissue in rodents and
    nonhuman primates with the hope of understanding,
    restoring, or replacing functions typically lost
    by neuronal degeneration in individuals with HD.
    Related areas of investigation include
    excitotoxicity (over stimulation of cells by
    natural chemicals found in the brain), defective
    energy metabolism (a defect in the mitochondria),
    oxidative stress (normal metabolic activity in
    the brain that produces toxic compounds called
    free radicals), tropic factors (natural chemical
    substances found in the human body that may
    protect against cell death).

7
state news
western Australia
This year has been a disappointing one for the WA
Branch, attendances at our sessions have been
variable and often poor a reflection of our
busy lives I guess. I also think there are a
number of other organizations that compete for
the neuroscience nurses including the MSNA,
Parkinsons special interest group,
Rehabilitation Nurses group etc. We all know
membership fees are costly and with family and
other commitments people make choices and I
believe this negatively impacts on our
membership. On the bright side we have held some
excellent educational sessions including sessions
on Cognition, MS, Stroke and the research done by
the Parkinsons Nurse Consultant on carers. Other
opportunities available to Members have been the
TCD workshop, the Trigeminal Neuralgia
presentation and the MS Awareness Week forums.
Increasingly we have seen the neurosurgical
nurses engage less with the Association hence the
focus on non surgical topics to encourage
attendance from the more active neurological
nurses. Our fundraising film night had great
potential but unfortunately with only 35 tickets
sold the potential wasnt realized but we did
make 122.50 profit. The biscuit sales were non
existent. No members expressed an interest in
attending the ANNA symposium but I understand
Catherine Bucholz and Jo McPhee (ex members non
financial) from SJOG attended with hospital
funding which is fantastic. The WCN is being held
in Sydney in November and I think this may have
distracted some members unable to attend
both. After 10 years as State Delegate for WA I
am not seeking nomination this year. Having
restarted the branch in 1995 and facilitating a
number of significant achievements including
several seminars which were videotaped, the
Professional Standards for Neuroscience Nurses
adopted nationally and the introduction of
National Neuroscience Nurses Day.
I believe it is time to hand over to new blood.
Since leaving the hospital system I have found it
increasingly difficult both time wise and with
networking as it is harder to access people
generally of site. Several key players have also
changed positions and / or left the system and
this has added to the difficulties faced in
generating interest and participation. I would
like to thank Lee for her work as secretary over
the last 12 months and Robyn for the great work
she did before that. I would also like to thank
that core of people who have attended the
meetings and helped with organising speakers and
events especially Harriet, Meg and Gill. I
would be happy to provide support to the new
position holders if necessary and hope that the
branch can be regenerated here in WA. Sue
Shapland State Delegate WA Branch ANNA September
2005
8
new south wales
queensland
Dear NSW members and Australasia members The NSW
branch held one of our most successful ever AGMs
prior to the annual conference. We were very
lucky to be supported by Medtronic and to have an
educational presentation on the management of
Hydrocephalus prior to the meeting. At the AGM we
welcomed Brianna Beattie to the NSW - Executive
as our weblinks assistant. Brianna is from Royal
North Shore Hospital and she will be working with
Anita Lloyd from Australasia to maintain the
links on our Webpage. In addition to this new
member we welcome Nicole Morley to the Executive.
At our next meeting we will be outlining Nicole's
new role - more of this in the next Brainstem
and Hemisphere News (the NSW newsletter
coordinated by Kylie Wright). Sadly I need to
advise members that the NSW - Secretary, Ms Heidi
Evans, will be retiring from her role after 5
years as our State Secretary. Never an easy task,
Heidi has helped us immeasurably with keeping our
meetings organised, minuted and allowing us to
use her own database for membership information -
in conjunction with that used by Australasia. I
would like to thank her for commitment to ANNA
and for all her efforts. A calendar will be going
out to NSW members shortly to advise of planned
events over the rest of the financial year but
before you get your Christmas events all planned
- Royal North Shore Hospital our hosting an ANNA
evening on the Wednesday 30th November 2005 from
5.30- 8.30pm. Refreshments are provided and the
meeting will take place in the Main Block, Level
13 Boardroom, Royal North Shore Hospital on the
Pacific Highway at St. Leonards. The contact
person for this event is Anne MacLeod on 9926
8074 or amacleod_at_nsccahs.health.nsw.gov.au. The
program for the evening is Onyx, Thrombolysis,
Research in Action and a Brain Bee Trivia Quiz.
Anne requests that members and non-members attend
and RSVP by 23rd November (especially to assist
with catering). Registration and payment may be
made on the night. Hope to see you there and for
those members who are not in the metropolitan
area who would like to be involved in an
education event - please contact me at
maureen.edgtton_at_swsahs.nsw.gov.au
I hope that all the members who attended the
conference enjoyed it. I have had some very
positive feedback from m colleagues here at the
Princess Alexandra Hospital. I was in the UK and
therefore unable to attend. In August, we were
guests of the Wesley Hospital, Brisbane for an
excellent informative presentation by Dr Peter
Silburn on Deep Brain Stimulation in the
treatment of Parkinson Disease. The next meeting,
which will be held on the 30th November is
sponsored by Novartis Pharmaceuticals and held in
Romeoss Italian Restaurant, Spring Hill. It will
feature Professor Mervyn Eadie presenting an
update on epilepsy. Contact me for further
information as space is limited. I am continuing
to send out journal articles by email, so any
Queensland member who does not receive them,
please let me know as this means I either dont
have your email address or I have the wrong
address. Any members who are unable to attend
meetings are encouraged to send in items for
discussion or requests for support. Sue Day Ph
07 3240 2137 Email sue_day_at_health.qld.gov.au
Maureen Edgtton-Winn Liverpool Hospital
Australian Nurse Practitioner Association
Supporting advanced nursing practice
2005 Report The Australian Nurse Practitioner
Association (ANPA) was officially formed in 2003.
The association aims to support and encourage
advanced nursing practice across specialties.
Members are committed to having a positive
influence over the clinical care and outcomes of
all patients and their families. Currently the
association has representatives from 5 states and
2 territories throughout Australia. Membership
has grown dramatically throughout the year. The
Inaugural Conference was held in October 2005 in
Canberra, ACT. Attendance exceeded expectations
with 170 delegates. Delegates included Nurse
Practitioners, aspiring Nurse Practitioners,
academics and other health professionals who
support advanced nursing practice. This exciting
and historic occasion provided opportunities for
all those involved to share knowledge, expertise
and commitment to clinical excellence Delegates
were also able to discuss future directions and
plans for advanced nursing practice. Keynote
speaker was Prof Donna Diers. Prof Diers
delivered a very inspiring address sharing
experiences and lessons learnt in the development
of advance nursing role development. More
information can be found at www.nursepractitioner
s.org.au Rochelle Firth Nurse Practitioner-
Neurosurgery Australian Nurse Practitioner
Association- Treasurer
9
Brainstem Questionnaire Collation
Earlier in the year we asked you for your
thoughts on your association newsletter. Here are
the results, and I hope that this issue starts to
reflect what you the members want ?And just as a
gentle reminder contributions from you the
members is greatly appreciated we would love to
know what is going on in the world of
neurosciences and hope that your good work is
shared amongst your professional peers
1. Could you please rate the following aspects of
brainstem currently
Comments Much improved after the facelift The
format is good Very Informative Inclusion of
articles by community nurses and carer
organisations to keep us informed and updated An
article on research stats on beneficial outcomes
of early rehabilitation. Invitations to physios
and OTs to contribute articles to
Brainstem. Have a particular interest in brain
tumours A research article on common
co-morbidities in neurological. Pts would be of
interest.
10
3. Please indicate whether you would like to see
any of the following in future editions of
Brainstem?
What other areas would you like to see covered
in Brainstem? WFNN Corner used to have in
journal few years ago Current trial (clinical
trials) Different types of neuro illness. I
would like clinical relevant data included-maybe
a topic an edition. All covered in
above Educational Opportunities Journal review
paragraph review Link page reviewed. Any other
comments/ suggestions? Many thanks for this
facelift of brainstem A job well done I like
brainstem to be in a newsletter format, with the
journal focus on clinical issues. More clinical
based information for current practicing nurses-
this will include people not able to attend
conferences. Appreciate all the work people put
in to get brainstem published. Issue 2 is a great
improvement from all previous issues.
11
  • Following this years AGM, several decisions need
    to be highlighted to members
  • membership rates shall be for a 12 month period
    i.e. if you applied in march, renewals will be
    expected in march the next year - pro rata rates
    will no longer apply. Each member will receive
    reminder renewals once the12 month period has
    passed
  • ANNA Exec and state delegates will have the
    discretion to distribute all members with
    appropriate notices via email

noticeboard
RNSH ANNA Education Evening
This education evening will be focusing on
interventional neuroradiological techniques,
primarily the use of thrombolysis in stroke and
onyx for the treatment of aneurysms and
AVMs. Royal North Shore Hospital November 30th
630pm 830pm Further information Anne
Macleod Light refreshments and supper will be
provided
Q I have an issue with taking the size of the
pupil when doing GCS. I knew that I should take
the size of the pupil before shining light, but
often many people misunderstand as to take the
size of the pupil after shining light.
Colleagues on my ward all think that it should be
the "post" one rather than the "pre" one. Could
you guys tell me which is the correct one?? As
much as possible, can you also send me journal
articles to support the say, so that I can show
it to my colleague?? Articles that I have found
generally talk about the different types of
response of pupils towards light but they don't
describe how to take the size of the pupil
Let everyone know about your education evenings
and advertise in Brainstem! Send information at
least 2 months before the event, including event,
date, venue, contact details Send information to
Rochelle McKnight Email annaexecutive_at_bigpond.com
.au Fax 02 9439 9029 Mail PO Box 6,
Artarmon, NSW 1570 Australia
A When we assess pupil size it is the resting
pupil size, that is before the light is shone in
the pupil. The references for this include
Joanne Hickey The Clinical Practice of
Neurological and Neurosurgical Nursing, 5th
edition and another useful journal article Shah,
S (1999). Neurological Assessment Nursing
Standard, 13 (22), 49-56
trivia
12
STROKE IT'S TIME! Call for Suggestions!
2nd Australasian Nursing Allied Health Stroke
Conference 6th 7th July 2006 Sydney, Australia
  • The aims of this conference will be
  • To highlight the timeframe for acute stroke care
  • To discuss innovations in stroke management and
    research
  • To promote new initiatives on stroke care
  • To provide the latest information on best
    practice in stroke
  • To provide a forum for stroke clinicians to share
    information
  • To raise awareness of rehabilitation concepts in
    stroke
  • To highlight rehabilitation practices by allied
    health
  • To raise community awareness of stroke
  • The Organising Committee request presentation
    ideas from prospective presenters participants
    to make this conference relevant and informative
    for all stroke clinicians.
  • Just give us your ideas on what you would like to
    hear more of.
  • This is a call for your suggestions!
  • The call for abstracts will be sent out in the
    near future based on your responses of what YOU
    want to hear about. We have provided the
    organising committees aims of the conference to
    help guide you.
  • Please send your ideas by the 31.10.05 to

Conference Secretariat Louise Pitney Conference
Action Pty Ltd, PO Box 576, Crows Nest, NSW
AUSTRALIA 1585 Tel 02 9437 9333 Fax 02 9901
4586 Email louise_at_conferenceaction.com.au
13
ANNA is continuing to recruit new association
members! It is always encouraging to see so many
new memberships in the mail ? On behalf of ANNA,
the executive would like to welcome the following
new members.
membership news
A reminder to members to notify the Association
promptly of change of address, we have been
receiving increasing numbers of returns of
late. If you have Email addresses please let the
executive know - by emailing us and we will then
be in a position to electronically mail you all
relevant association documentation.
14
membership news
Membership renewals are now overdue with names of
unfinancial members now removed from our active
membership lists and from future mail outs. If
you have colleagues who are concerned at their
current financial status please advise them to
contact the executive for clarification.
15
What the???
Onyx, a new embolization material
As a result of high blood flow and pressure
imbalances, Intracranial arterio-venous
malformations (AVM) are at risk of hemorrhage, or
rupture, which can lead to stroke, severe
disability and even death. They often represent a
complex clinical problem in regards to treatment,
the choice of treatment and the technical
difficulties related to treatment.
Treatment options for AVMs include catheter-based
therapies, surgery, radiation therapy, or a
combination of these treatments. Catheter-based
treatments involve the delivery of embolic
materials to occlude, or block, the abnormal
blood vessels comprising the AVM.
Onyx is a liquid embolic material that is
delivered by neurovascular specialists through
micro catheters directly into a vascular defect,
such as a brain aneurysm or AVM, in a very
controlled manner. After delivery of the embolic
material, it stays in liquid form until it comes
into contact with blood or other aqueous
solutions.
Once contact is made, Onyx begins to precipitate,
changing from liquid to a solid thereby sealing
off the vessels in the AVM from blood flow and
reducing the risk of rupture. Endovascular
embolization can reduce the size and vascularity
of the AVM, thereby facilitating safer and easier
surgical resection
Opaque can be seen radiologically Slow
injection for exact placement. Non-adhesive
easy injection with microcatheters
Disadvantages Vascular toxicity, vasospasm
necrosis. By-products of Onyx are released by
lungs producing an unpleasant smell. Cost
approx. 2000 per vial
Post insertion of onyx, the AVM no longer has a
blood supply
16
Annual General Meeting Minutes 17th September,
2005 Legends Hotel, Gold Coast, QLD
  • Attendance Tracy Desborough, Sharon Eriksson,
    Cheryl Trudinger, Jennifer Blundell, Suzy
    Goodman, Carley Mills, Rochelle McKnight, Joanne
    McLoughlin, Terri Pinkis, Tania Heywood, Sue de
    Lange, Phillipa Balfour, Kellie McIntosh, Helen
    Houridis, Brianna Beattie, Allison ODea, Saskia
    Baaijens, Ros Nicholson, Karen OMalley, Tim
    OMalley, Barbara Lester, Lynette Wallace, Dallas
    Tucker, Sharryn Byers, Michael Sham, Anne
    MacLeod, Rochelle Firth, Vicki Evans, Jeanne
    Barr, Rosey Merheb, Mary Wyer, Penny Bayliss,
    Nerolie Lyle, Karen Tuqiri,
  • Apologies Angela, Maureen Edgtton-Winn, Sue Day,
    Denise Le Lievre, Jane Henry, Joan Johnson, Sue
    Astegno, Brooke Lederman, Jill Stow, Naomi Moody,
    Eithnie Irving, Mary Lomas
  • Proxies
  • Chair Tracy Desborough
  • 4.Confirmation of previous minutes Lynette
    Wallace Seconded Sharryn Byers

17
Meeting closed 1550 Next meeting Cairns
September 2006
18
WORLD FEDERATION OF NEUROSCIENCE NURSES 2005
Update
Following a successful 9th Congress, Barcelona-
Spain, plans for the 10th Congress are under way.
The location of the next congress has yet to be
decided. To ensure the quality, efficiency and
support for congress preparations it was decided
that prospective host countries were to provide
submissions for consideration. Submissions are
due at the end of 2005 and congress location for
2009 will be announced at the beginning of 2006.
A Membership, Education, Research Committee
(MERC) has been formed. This is to ensure ongoing
development and opportunities for neuroscience
nurses. It is expected that the MERC will prove
to be extremely valuable in the growth of WFNN
and its members. There has been further
development in the Nurse Exchange Program with a
proposed sponsorship contract from Johnson and
Johnson. Details are still being finalised
however this program will create wonderful
opportunities for neuroscience nurses to exchange
practices and ideas. Ongoing information will be
updated on the web site www.wfnn.nu Rochelle
Firth Nurse Practitioner- Neurosurgery WFNN-
Secretary
Australasian Executive Contact Details
PO Box 6, Artarmon NSW 1570 AUSTRALIA annaexecutiv
e_at_bigpond.com.au phone 9926 7527 fax 02 9439
9029
About PowerShow.com